Log In
BCIQ
Print this Print this
 

CSL346

  Manage Alerts
Collapse Summary General Information
Company CSL Ltd.
DescriptionHumanised mAb against vascular endothelial growth factor B (VEGF-B)
Molecular Target Vascular endothelial growth factor B (VEGF-B)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentDiscovery
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today